Brief: Haemonetics Q4 revenue USD 304.4 million
11/05/2023 11:21
May 11 (Reuters) - Haemonetics Q4 gross margin 51.3%. * Q4 revenue USD 304.4 million * Q4 operating income USD 35.3 million
Recent news on Haemonetics
See all newsBrief: Haemonetics Announces FDA Approval Of Perqseal® Elite Vascular Closure System
Haemonetics says FDA clears vascular closure device
US STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Haemonetics surges as CSL plans to move all US plasma centers to its devices